Rational Advisors LLC Eli Lilly & CO Transaction History

Rational Advisors LLC

$940 Million
Q3 2024

A detailed history of Rational Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Rational Advisors LLC holds 3,600 shares of LLY stock, worth $2.82 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

3,600

Previous 4,009 10.2%

Holding current value

$2.82 Million

Previous $3.63 Million 12.12%

% of portfolio

0.34%

Previous 0.39%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$772.14 - $960.02 $315,805 - $392,648	-409 Reduced 10.2%	3,600 $3.19 Million
Q2 2024 Jul 25, 2024	BUY	$724.87 - $909.04 $187,741 - $235,441	259 Added 6.91%	4,009 $3.63 Million
Q1 2024 Apr 23, 2024	BUY	$592.2 - $792.28 $2.22 Million - $2.97 Million	3,750 New	3,750 $2.92 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $434,700 - $599,300	-1,000 Reduced 22.73%	3,400 $1.83 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $420,888 - $562,776	-1,200 Reduced 21.43%	4,400 $2.06 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $1.09 Million - $1.28 Million	3,515 Added 168.59%	5,600 $1.92 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $143,411 - $167,102	-446 Reduced 17.62%	2,085 $763,000
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $750,390 - $855,148	2,531 New	2,531 $818,000
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $47,356 - $62,664	-363 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $50,299 - $58,180	344 Added 1810.53%	363 $53,000
Q2 2020 Aug 10, 2020	BUY	$136.42 - $164.18 $2,591 - $3,119	19 New	19 $3,000
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $2,738 - $3,389	-23 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$106.92 - $132.43 $13,365 - $16,553	-125 Reduced 84.46%	23 $3,000
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $122,167 - $132,887	-1,144 Reduced 88.54%	148 $17,000
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $3.14 Million - $3.66 Million	-28,340 Reduced 95.64%	1,292 $143,000
Q1 2019 May 08, 2019	BUY	$111.31 - $131.02 $1.13 Million - $1.33 Million	10,132 Added 51.96%	29,632 $3.85 Million
Q4 2018 Feb 07, 2019	BUY	$105.9 - $118.64 $545,385 - $610,996	5,150 Added 35.89%	19,500 $2.26 Million
Q3 2018 Nov 08, 2018	BUY	$85.86 - $107.31 $1.09 Million - $1.37 Million	12,738 Added 790.2%	14,350 $1.54 Million
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $583,041 - $669,149	-7,702 Reduced 82.69%	1,612 $138,000
Q1 2018 May 18, 2018	BUY	$74.21 - $87.6 $468,561 - $553,106	6,314 Added 210.47%	9,314 $720,000
Q4 2017 Feb 08, 2018	SELL	$81.94 - $87.89 $49,164 - $52,734	-600 Reduced 16.67%	3,000 $253,000
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $277,452 - $307,944	3,600	3,600 $308,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rational Advisors LLC with notifications on news.

Account

Rational Advisors LLC Eli Lilly & CO Transaction History